RTI Surgical® Showcases Advancements in Spine Portfolio and Clinical Data at NASS 2019
25 sept. 2019 07h05 HE
|
RTI Surgical Holdings, Inc.
CHICAGO, Sept. 25, 2019 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, will showcase its expanding portfolio and body of clinical data to...
Globus Medical Showcases Latest Innovations at NASS 2019
19 sept. 2019 16h15 HE
|
Globus Medical
AUDUBON, Pa., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will highlight the company’s latest spinal implant and enabling...
Xtant(TM) Medical Exhibits at North American Spine Society (NASS) Meeting
12 oct. 2015 13h13 HE
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Oct. 12, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced...
Mesoblast's Phase 2 Trial Results In Chronic Low Back Pain Presented at North American Spine Society Annual Meeting
12 nov. 2014 18h36 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Mesoblast's Phase 2 trial results in degenerative disc disease were presented today at the North American Spine Society (NASS)...
Mesoblast's Phase 2 Trial For Lumbar Spinal Fusion Selected For Presentation at Premier Spine Conference
18 sept. 2013 23h02 HE
|
Mesoblast
MELBOURNE, Australia and NEW YORK, Sept. 18, 2013 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) today announced that the Phase 2 clinical trial using the...